Author Archives: admin
Altitude Lab Relocates to Gateway’s BioHive Hub
Altitude’s new facility will be housed within Recursion’s expanded headquarters and will promote increased collaboration in Downtown Salt Lake City’s rapidly growing biotech innovation ecosystem.SALT LAKE CITY, May 25, 2023 (GLOBE NEWSWIRE) — Altitude Lab announced today that its incubator program and facility will leave Research Park to grow its operation in the Gateway’s BioHive […]
Clene Awarded Grant From National Multiple Sclerosis Society to Advance Development of CNM-Au8® in Non-Active Progressive Multiple Sclerosis
SALT LAKE CITY, May 25, 2023 (GLOBE NEWSWIRE) — Clene, Inc. (Nasdaq: CLNN), along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced that Clene has received a grant from the National Multiple Sclerosis Society (NMSS) via the […]
Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
Model expected to accelerate deployment of KidneyIntelX across key U.S. regions with high rates of diabetic kidney disease and established insurance coverage LONDON and CHICAGO, May 25, 2023 (GLOBE NEWSWIRE) — Renalytix (NASDAQ: RNLX) (LSE: RENX), the first company to develop and commercialize an artificial intelligence (AI) powered in-vitro diagnostic for kidney disease, has selected […]
MedVenture Health Acquires Canyon Labs in Move to Bolster Services
In a strategic move to further enhance its service offering, MedVenture Health has announced the acquisition of Canyon Labs to add regulatory and laboratory testing services to its deep portfolio. SALT LAKE CITY, UT / ACCESSWIRE / May 19, 2023 / MedVenture Health, a specialized private investment firm devoted to the advancement of medical devices, […]
Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer
Biomarker offers another companion diagnostic option to establish eligibility for FDA-approved drug ELAHERE® SALT LAKE CITY, May 24, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the addition of Folate Receptor Alpha (FRα) to its Precise™ Oncology Solutions portfolio. The new biomarker adds another […]
Canary Speech Accelerates AI Speech Analysis Technology with Microsoft Cloud for Healthcare Integration
Digital vocal biomarker innovator integrates clinical-grade technology providing real-time speech analysis on Microsoft Cloud for Healthcare. PROVO, Utah, May 24, 2023 /PRNewswire/ — Canary Speech, Inc. announced today that it will apply the power of artificial intelligence (AI) voice analysis technology to address a variety of mental health challenges and enable early intervention, reduce healthcare […]
Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor after Transition
EAGAN, MN / ACCESSWIRE / May 18, 2023 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional […]
House Health Panel Advances Legislation on PBM’s, Generic Drugs
The Energy and Commerce Health Subcommittee on Wednesday voted to advance a series of healthcare bills, largely on a bipartisan basis. The bills included reforms to the practices of pharmacy benefit managers (PBMs), improving access to generic drugs, and increasing transparency into the prices that hospitals, laboratories, and insurance companies charge. Of particular interest to the life […]
Teva Launches New “Pivot to Growth” Strategy
Return to growth by accelerating a strong innovative medicines portfolio Expand innovative pipeline and focus on core therapeutic areas with first-in-class and best-in-class opportunities Sustain generics powerhouse based on high-value and complex products Focus the business on areas with the greatest potential for growth and patient impact TEL AVIV, Israel–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. […]
U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform
Transit Scientific awarded increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology for use with standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons. Park City, Utah USA, May 18, 2023. Transit Scientific, a Utah-based medical device company, today announced newly issued expanded U.S. patent protection for the XO exoskeleton sheath platform from the United States Patent and Trademark Office […]
BD Launches World’s First Spectral Cell Sorter with High-Speed Cell Imaging
FRANKLIN LAKES, N.J., May 18, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new-to-world cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments. […]
Michele Baptista Joins CenExel Industry powerhouse brings expertise in early phase clinical trial services to CenExel site network
Salt Lake City, Utah — CenExel announces the addition of Michele Baptista as the new Senior Director of Business Development. In this new capacity, Michele will be responsible for developing, selling, and supporting CenExel’s 18-site network for early phase clinical trials, while also identifying new business opportunities and expanding CenExel’s customer base. Michele joins CenExel from WCG IRB, where she […]
